Related references
Note: Only part of the references are listed.Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
Marie Robin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
Naseema Gangat et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
Ayalew Tefferi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Outcome of Transplantation for Myelofibrosis
Karen K. Ballen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis
Kebede Hussein et al.
BLOOD (2010)
Comparison of prognostic scoring systems in primary myelofibrosis
Pierre Morel et al.
BLOOD (2010)
Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis
Francesco Passamonti et al.
BLOOD (2010)
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis
Haefaa Alchalby et al.
BLOOD (2010)
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type
A. Bacigalupo et al.
BONE MARROW TRANSPLANTATION (2010)
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Francisco Cervantes et al.
BLOOD (2009)
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Nicolaus Kroeger et al.
BLOOD (2009)
Risk Score for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation A Retrospective Analysis
Alois Gratwohl et al.
CANCER (2009)
Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Constantine S. Tam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
F. Cervantes et al.
LEUKEMIA (2008)
Validation and comparison of contemporary prognostic models in primary myelofibrosis - Analysis based on 334 patients from a single institution
Ayalew Tefferi et al.
CANCER (2007)
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia
Daniella M. B. Kerbauy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis
N Kröger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
HJ Deeg et al.
BLOOD (2003)
Share Paper
